Corrigendum to “Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway” [Canc. Lett. 342 (2014) 150–158]
Zhiqiang Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin Wang(Soochow University), Yuanzhong Wu(Sun Yat-sen University), Dawei Liu(Australian Research Council), Jingnan Shen(Sun Yat-sen University), Jinchang Lu(Yixing Tumor Hospital), Qinglian Tang(Sun Yat-sen University), Tiebang Kang(Sun Yat-sen University), Jun-Qiang Yin(Sun Yat-sen University), Man-Si Wu(Guangzhou University of Chinese Medicine), Changye Zou(Sun Yat-sen University), Xianbiao Xie(Fujian Medical University)
Cited by 2
Related Papers
RAB31 marks and controls an ESCRT-independent exosome pathway
|Cell Research|2020|472
Targeting BMI1 + Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma
|Cell stem cell|2017|291
N6-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma
|Cancer Research|2019|267
Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota
|Biomedicine & Pharmacotherapy|2019|196
Activation of Pro-gelatinase B by Endometase/Matrilysin-2 Promotes Invasion of Human Prostate Cancer Cells
|Journal of Biological Chemistry|2003|129